Stiller, M J <br/><br/>
A double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitis.  [electronic resource] 

 -  Journal of the American Academy of Dermatology  Apr 1994 
 - 597-602 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0190-9622 
<br/><br/><label>Standard No.: </label>10.1016/s0190-9622(94)70068-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Child<br/>Dermatitis, Atopic--drug therapy<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Male<br/>Middle Aged<br/>Severity of Illness Index<br/>Thymopentin--therapeutic use<br/>Time Factors<br/>Treatment Outcome